BGI Genomics Co (SZSE:300676) Days Sales Outstanding : 167.09 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co Days Sales Outstanding?

BGI Genomics Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥1,504 Mil. BGI Genomics Co's Revenue for the three months ended in Mar. 2024 was ¥821 Mil. Hence, BGI Genomics Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 167.09.

The historical rank and industry rank for BGI Genomics Co's Days Sales Outstanding or its related term are showing as below:

SZSE:300676' s Days Sales Outstanding Range Over the Past 10 Years
Min: 60.05 Med: 114.84 Max: 153.44
Current: 133.07

During the past 12 years, BGI Genomics Co's highest Days Sales Outstanding was 153.44. The lowest was 60.05. And the median was 114.84.

SZSE:300676's Days Sales Outstanding is ranked worse than
76.82% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.44 vs SZSE:300676: 133.07

BGI Genomics Co's Days Sales Outstanding declined from Mar. 2023 (180.19) to Mar. 2024 (167.09).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

BGI Genomics Co Days Sales Outstanding Historical Data

The historical data trend for BGI Genomics Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGI Genomics Co Days Sales Outstanding Chart

BGI Genomics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

149.35

60.05

74.84

88.70

153.44

BGI Genomics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															180.19	128.81	132.68	112.38	167.09

Competitive Comparison of BGI Genomics Co's Days Sales Outstanding

For the Diagnostics & Research subindustry, BGI Genomics Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BGI Genomics Co's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BGI Genomics Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BGI Genomics Co's Days Sales Outstanding falls into.

BGI Genomics Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BGI Genomics Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2213.002	+	1443.947)	/	2 )	/	4349.637	*	365
=	1828.4745					/	4349.637	*	365
=	153.44

BGI Genomics Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (1443.947	+	1563.706)	/	2 )	/	821.25	*	365 / 4
=	1503.8265					/	821.25	*	365 / 4
=	167.09

BGI Genomics Co (SZSE:300676) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

BGI Genomics Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

BGI Genomics Co (SZSE:300676) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083

Website

http://www.bgi.com

BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.

Executives

Wang Jian	Director
Liu Na	Executives
Sun Ying Jun	Director
Yin Ye	Directors, executives
Du Yu Tao	Directors, executives
Li Song Gang	Supervisors
Hu Yu Jie	Supervisors
Xu Qian	Secretary Dong
Li Zhi Ping	Executives
Chen Yi Qing	Executives
Li Wen Qi	Supervisors

BGI Genomics Co (SZSE:300676) Headlines

No Headlines